Gene · 800
Papers3,413
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,413
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A case report of recurrent leiomyosarcoma with chondrosarcoma differentiation in the abdominal wall and a review of the literature. | Pathol Oncol Res | 2023 | 37235202 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing and traditional RNA sequencing reveals the role of cancer-associated fibroblasts in oral squamous cell carcinoma cohort. | Front Oncol | 2023 | 37234985 | PubTator, text mining | PubMed |
| An Unconventional Regimen of Carboplatin and Paclitaxel in Metastatic Colorectal Carcinosarcoma: A Case Report and Review of Literature. | Curr Oncol | 2023 | 37232827 | PubTator, text mining | PubMed |
| Proximity labelling identifies pro-migratory endocytic recycling cargo and machinery of the Rab4 and Rab11 families. | J Cell Sci | 2023 | 37232246 | PubTator, text mining | PubMed |
| Primary Vaginal Epithelioid Angiosarcoma: A Case Report and Literature Review of a Rare Neoplasm. | Cureus | 2023 | 37228354 | PubTator, text mining | PubMed |
| Pelvic leiomyoma associated with intermediate risk prostate cancer: A case report. | Urol Case Rep | 2023 | 37228257 | PubTator, text mining | PubMed |
| PD-L1 expression, morphology, and molecular characteristic of a subset of aggressive uterine tumor resembling ovarian sex cord tumor and a literature review. | J Ovarian Res | 2023 | 37221583 | PubTator, text mining | PubMed |
| S100A6 inhibits MDM2 to suppress breast cancer growth and enhance sensitivity to chemotherapy. | Breast Cancer Res | 2023 | 37217945 | PubTator, text mining | PubMed |
| High cardiac output state due to pelvic arterio-venous shunt: a case report and review of the literature. | ESC Heart Fail | 2023 | 37216928 | PubTator, text mining | PubMed |
| Single-cell RNA-sequence analysis of human bone marrow reveals new targets for isolation of skeletal stem cells using spherical nucleic acids. | J Tissue Eng | 2023 | 37216034 | PubTator, text mining | PubMed |
| Clinically Aggressive Uterine Epithelioid Leiomyosarcoma with Rhabdomyoblastic Differentiation and High Proliferation Rate: A Case Report. | Am J Case Rep | 2023 | 37190674 | PubTator, text mining | PubMed |
| Clinical Outcome of Low-Grade Myofibroblastic Sarcoma in Japan: A Multicenter Study from the Japanese Musculoskeletal Oncology Group. | Cancers (Basel) | 2023 | 37190242 | PubTator, text mining | PubMed |
| Targeting P21-Activated Kinase-1 for Metastatic Prostate Cancer. | Cancers (Basel) | 2023 | 37190165 | PubTator, text mining | PubMed |
| Breast Sarcomas-How Different Are They from Breast Carcinomas? Clinical, Pathological, Imaging and Treatment Insights. | Diagnostics (Basel) | 2023 | 37189471 | PubTator, text mining | PubMed |
| Genome-wide analysis of RNA-binding proteins co-expression with alternative splicing events in mitral valve prolapse. | Front Immunol | 2023 | 37180137 | PubTator, text mining | PubMed |
| Redefining normal breast cell populations using long noncoding RNAs. | Nucleic Acids Res | 2023 | 37144467 | PubTator, text mining | PubMed |
| Peroxisomal defects in microglial cells induce a disease-associated microglial signature. | Front Mol Neurosci | 2023 | 37138705 | PubTator, text mining | PubMed |
| Paraganglioma in a Young Adult Female Patient: A Case Report. | Cureus | 2023 | 37131552 | PubTator, text mining | PubMed |
| Dependency of NELF-E-SLUG-KAT2B epigenetic axis in breast cancer carcinogenesis. | Nat Commun | 2023 | 37117180 | PubTator, text mining | PubMed |
| A prognostic model for bladder cancer based on cytoskeleton-related genes. | Medicine (Baltimore) | 2023 | 37115085 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/800/papers?page=19